Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant CD3 epsilon anticorps

L’anticorps Souris Monoclonal anti-CD3 epsilon a été validé pour ELISA, Func, Neut et IGA. Il convient pour détecter CD3 epsilon dans des échantillons de Humain.
N° du produit ABIN7795311

Aperçu rapide pour Recombinant CD3 epsilon anticorps (ABIN7795311)

Antigène

Voir toutes CD3 epsilon (CD3E) Anticorps
CD3 epsilon (CD3E)

Type d'anticorp

Recombinant Antibody

Reactivité

  • 351
  • 207
  • 51
  • 43
  • 21
  • 19
  • 8
  • 8
  • 8
  • 7
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 209
  • 175
  • 47
  • 38
  • 23
  • 12
  • 7
  • 2
  • 2
  • 1
  • 1
Souris

Clonalité

  • 394
  • 115
  • 7
Monoclonal

Conjugué

  • 180
  • 39
  • 35
  • 24
  • 23
  • 12
  • 11
  • 11
  • 11
  • 11
  • 11
  • 11
  • 8
  • 8
  • 8
  • 8
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CD3 epsilon est non-conjugé

Application

  • 368
  • 217
  • 182
  • 133
  • 118
  • 87
  • 47
  • 33
  • 32
  • 27
  • 27
  • 22
  • 21
  • 14
  • 13
  • 8
  • 6
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Functional Studies (Func), Neutralization (Neut), Immunogenicity Assay (IGA)

Classe de qualité

In vivo Grade

Clone

OKT3
  • Expression System

    Mammalian cells

    Fonction

    In vivo Grade Recombinant Anti-human CD3e Monoclonal Antibody, Mouse IgG2a Kappa (Clone: OKT3)

    Attributs du produit

    The OKT3 antibody binds to CD3 epsilon of the T cell receptor-CD3 complex found only on mature T cells and medullary thymocytes. An interaction between T cells, OKT3, and monocytes causes T-cell activation (mitogenesis) in vitro. On the other hand, the OKT3 antibody blocks the unique association between the antigen receptor and CD3, and both the generation and function of cytotoxic T cells. After an initial dose of the OKT3 antibody, T cells disappear from the circulation within minutes to hours. During treatment with the OKT3 antibody, T cells bearing the usual array of surface molecules (CD2, CD4, and CD8) reappear in the peripheral blood circulation but these cells are devoid of CD3. After another 48 hours without the OKT3 antibody, the normal array of surface molecules including CD3 appear again on all T cells. The selective removal of CD3 by internalization is thought to be the key mechanism of action of the OKT3 antibody. Comodulation of the antigen receptor with CD3 explains the immunoblocking action of the OKT3 antibody in vivo. The OKT3 antibody is ineffective clinically if the CD3 target molecule is not modulated. The OKT3 antibody is effective for induction of immunosuppression and for treating initial and steroid-resistant rejections.

    Purification

    Protein A or G affinity column

    Pureté

    >95 % by reducing SDS-PAGE

    niveau d'endotoxine

    < 1 EU per 1 mg of the protein by the LAL method

    Isotype

    IgG2a
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    > 3 mg/mL

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
  • Antigène

    CD3 epsilon (CD3E)

    Autre désignation

    CD3e

    Pathways

    TCR Signaling, CXCR4-mediated Signaling Events, Ubiquitin Proteasome Pathway
Vous êtes ici:
Chat with us!